I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Infigratinib in Recurrent Glioblastoma Patients
This trial is an open-label, multicenter, Phase 0 trial that will enroll up to 20 participants with recurrent high-grade glioma with FGFR1 K656E or FGFR3 K650E mutation or FGFR3-TACC3 translocation which are scheduled for resection. In the lead-in cohort, a total of 20 participants will be enrolled into the proposed …
contrast-enhanced magnetic resonance imaging
conjugated bilirubin
renal function
FGFR1
hysterectomy
- 0 views
- 19 Feb, 2024